Windy City Media Group Frontpage News

THE VOICE OF CHICAGO'S GAY, LESBIAN, BI, TRANS AND QUEER COMMUNITY SINCE 1985

home search facebook twitter join
Gay News Sponsor Windy City Times 2023-12-13
DOWNLOAD ISSUE
Donate

Sponsor
Sponsor
Sponsor

  WINDY CITY TIMES

AIDS: Advocates support approval of PrEP
From a news release
2012-05-01

This article shared 2828 times since Tue May 1, 2012
facebook twitter google +1 reddit email


New York, May 1, 2012 — In public comments submitted this week, a group of 14 leading HIV/AIDS and health organizations stated their support for Food and Drug Administration ( FDA ) approval of emtricitabine/ tenofovir disoproxil fumarate ( TDF/FTC or Truvada® ) as pre-exposure prophylaxis ( PrEP ) to prevent HIV infection in adult men and women. Their comments, submitted in advance of a May 10 FDA Advisory Committee meeting, pointed to compelling evidence on the efficacy of TDF/FTC as PrEP and highlighted the unique potential of this intervention to help slow the HIV epidemic in the US.

With PrEP, HIV-negative individuals who are at risk for HIV take anti-HIV medications in order to reduce their chances of becoming infected if exposed to the virus. At the May 10 hearing, the FDA will consider data from clinical trials showing that TDF/FTC reduced the risk of sexual transmission of HIV in populations including men who have sex with men ( MSM ) and heterosexual women and men.

"The US and international AIDS community overwhelmingly supports FDA's priority review of this potentially game-changing new tool to prevent HIV," said Mitchell Warren, executive director of AVAC. "The evidence is increasingly clear that daily PrEP can help reduce HIV risk in women and men who take it consistently as prescribed. While no single tool will be enough to stop the spread of HIV, PrEP could be a vital part of a comprehensive, global strategy to end the AIDS epidemic."

Despite some progress in reducing HIV incidence using other available methods, approximately 50,000 people become newly infected with HIV every year in the United States, and 2.6 million people were newly infected with HIV worldwide in 2010. Globally, half of all people infected with HIV are women and girls. In the United States, HIV infection continues to take a disproportionate toll on African Americans and Latinos; MSM, including transgender individuals; and the poor. Driving down HIV infection rates is a primary objective of the U.S. National HIV/AIDS Strategy, and is at the core of global efforts to end the AIDS epidemic.

"Today's HIV prevention tools, including condoms, remain as essential as ever, but it's clear that they aren't enough," said Deborah Cohan of the Bay Area Perinatal AIDS Center. "If approved, PrEP would help address important gaps, including the need for women to have more ways to protect themselves without having to rely on their male partners."

"Evaluation of new prevention tools is critical to reducing the devastating impact of HIV among Black Americans," said Douglas Brooks, MSW, Senior Vice President of the Justice Resource Institute. "No single approach will be right for everyone, but PrEP could offer a much needed option for some. The benefits could be especially great for Black gay or bisexual men, who account for nearly one-quarter of new HIV infections in our nation today."

Modeling studies have shown that widespread access to PrEP could reduce new HIV infections, and thus the scale of the global HIV epidemic, substantially around the world. The FDA's decision on TDF/FTC as PrEP could help pave the way for global health funders and developing countries to step up their planning for implementation.

Evidence for PrEP: What the Science Tells Us

At the May hearing, an FDA Advisory Committee will consider data from a wide range of safety and efficacy studies, including two pivotal clinical trials of TDF/FTC as PrEP:

The Partners PrEP trial, which found that daily TDF/FTC reduced HIV infections by 73 percent among heterosexual couples in Africa in which one partner was HIV infected and the other was not. Efficacy was 90 percent among those who adhered closely to their daily drug regimen.

An international study called iPrEx found that daily use of the drugs reduced HIV infections by 42 percent among MSM, and by more than 90 percent among participants who took their medication consistently enough for the drug to be detected in their blood.

These studies demonstrate that PrEP was safe, with minimal side effects and no significant risk of drug resistance. These and other trials also indicate that effectiveness of TDF/FTC as PrEP depends greatly on individuals' adherence to the PrEP regimen. In each trial, when adherence was low, there was low or no protection, pointing to the central importance of strategies to maximize adherence.

"If FDA approves PrEP, we'll still have a lot of work to do, just as with any other new drug. We'll have many questions to answer in order to use PrEP effectively to reduce HIV infections," said David Munar, President and CEO of the AIDS Foundation of Chicago. "The essential next step will be to launch additional demonstration projects in a wide range of populations and settings. These real-world projects will help us understand how to achieve higher levels of adherence, how to best combine PrEP with other approaches, and which specific populations can benefit the most. While a handful of these real-world studies are now being planned, we need to pick up the pace."

Summary of the Joint Comments to FDA

Based on the clinical trial results to date, the groups indicated their support for FDA approval of TDF/FTC among both men and women. They also highlighted evidence demonstrating the safety of TDF/FTC when used as PrEP, while urging the FDA to ensure appropriate labeling and post-marketing surveillance to ensure that any future safety concerns will be quickly identified and addressed. In addition, the groups also called for the full participation of communities most likely to benefit from PrEP in any future discussions about FDA-required educational/informational materials and programs to support safe use of TDF/FTC as PrEP.

The full text of the comments is available at www.avac.org/ht/a/GetDocumentAction/i/43821. The comments were signed by the following organizations:

AIDS Foundation of Chicago

AIDS United

AVAC: Global Advocacy for HIV Prevention

Bay Area Perinatal AIDS Center

Black AIDS Institute

The Fenway Institute

International Rectal Microbicide Advocates

Justice Resource Institute

National Black Gay Men's Advocacy Coalition ( NBGMAC )

National Minority AIDS Council ( NMAC )

Project Inform

San Francisco AIDS Foundation

SHERO Empowerment Network

SisterLove


This article shared 2828 times since Tue May 1, 2012
facebook twitter google +1 reddit email

Out and Aging
Presented By

  ARTICLES YOU MIGHT LIKE

Gay News

Brown Elephant Returns To Northalsted
2024-03-26
Brown Elephant's Lake View location is moving to Northalsted and already accepting donations. Howard Brown Health, the largest LGBTQ+ health center in the midwest, operates three Brown Elephant resale shops in the Chicagoland area to help ...


Gay News

An interstate trans healthcare crisis: Illinois prepares for influx of people seeking gender-affirming care
2024-03-26
With hard-won rights, such as access to hormone replacement therapy or permission to use one's chosen pronouns in school, breaking down in states across the country, trans residents of all ages are left with a choice: ...


Gay News

Planned Parenthood of Illinois expands Orland Park health center
2024-03-26
--From a press release - ORLAND PARK, Ill. - Planned Parenthood of Illinois (PPIL) announces the expansion of its existing Orland Park Health Center at 14470 S. LaGrange Rd., Suite 106. The 1,800-square-foot expansion is projected to increase sexual and reproductive ...


Gay News

Wyoming is latest state to ban gender-affirming care for minors
2024-03-24
On March 22, Wyoming became the latest state to prohibit gender-affirming care for minors, The Hill noted. In doing so, it joined 23 other states that passed laws restricting or banning the treatment. Legislators in both ...


Gay News

Chicago's LGBTQ+ Advisory Council sets a new course
2024-03-18
Chicago's LGBTQ+ Advisory Council held its first meeting of the calendar year on Feb. 28 at City Hall in the Loop under the leadership of the recently appointed chair Jin-Soo Huh. The LGBTQ+ Advisory Council is ...


Gay News

WORLD Leaked messages, Panama action, author dies at 32, Japan court, out athletes
2024-03-15
Hundreds of messages from an internal chat board for an international group of transgender health professionals were leaked in a report and framed as revealing serious health risks associated with gender-affirming care, including cancer, according to ...


Gay News

UK health service to stop routinely prescribing puberty blockers to minors
2024-03-14
NHS (National Health Service) England confirmed that children will no longer routinely be prescribed puberty blockers at gender-identity clinics, the BBC reported. The decision came after a review found there was "not enough evidence" that they ...


Gay News

One Roof Chicago launches youth-focused workforce development program
2024-03-14
One Roof Chicago (ORC) is set to launch its first training, education and job placement program for LGBTQ+ young adults in late spring. This Community Health Workers and Elder Care program is a part of ORC's ...


Gay News

Howard Brown experts discuss advocacy and allyship for Chicago's trans community
2024-03-14
By Alec Karam - Howard Brown Health's Trans & Gender Diverse People's Rights & Patient Care panel convened March 12 to discuss both resources for—and opportunities to provide allyship to—the city's trans and gender diverse communities. The event hos ...


Gay News

Howard Brown Health faces October trial if settlement isn't reached with union
2024-03-13
Howard Brown Health could go to trial over unfair labor practice allegations if the LGBTQ+ health center doesn't reach a settlement with its agreement soon. Chicago's regional director of the National Labor Relations Board (NLRB) filed ...


Gay News

Longtime LGBTQ+-rights activist David Mixner dies at 77
2024-03-12
On March 11, longtime LGBTQ+ and HIV/AIDS activist David Mixner—known for working on Bill Clinton's presidential campaign but then splitting from him over "Don't Ask, Don't Tell" (DADT)—died at age 77, The Advocate reported. ...


Gay News

Pro-choice activists protest crisis pregnancy center on International Women's Day
2024-03-11
The rainy weather on March 8 didn't deter a passionate group of pro-choice protesters from gathering in Old Town on International Women's Day. Following the opening of Women's Care Center—a crisis pregnancy center—directly next to Pl ...


Gay News

NATIONAL Altercation, mpox research, Univ. of Fla., George Santos, tech battle
2024-03-08
Video footage uploaded to Facebook showed an altercation between a state trooper and two prominent Philadelphia LGBTQ+ leaders, the Washington Blade reported, republishing an article from Philadelphia Gay News. Celena ...


Gay News

Pride 365 event emphasizes year-round support for LGBTQ+ employees
2024-03-07
Queer employees are queer all year-round. The need for employers to accordingly support and uplift them year-round was the core message at Howard Brown Health and Citywide Pride's Pride 365 "Out of Office to Out in ...


Gay News

AMA launches toolkit to increase screenings for HIV, STIs, hepatitis, tuberculosis
2024-03-06
Press release - CHICAGO — With disruptions in clinical care caused by the COVID-19 pandemic and increasing rates of sexually transmitted infections (STIs) and viral hepatitis across the U.S., the American Medical Association ...


 


Copyright © 2024 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.

All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transgender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 
 

TRENDINGBREAKINGPHOTOS







Sponsor


 



Donate


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots
Identity      BLACKlines      En La Vida      Archives      Advanced Search     
Windy City Queercast      Queercast Archives     
Press  Releases      Join WCMG  Email List      Email Blast      Blogs     
Upcoming Events      Todays Events      Ongoing Events      Bar Guide      Community Groups      In Memoriam     
Privacy Policy     

Windy City Media Group publishes Windy City Times,
The Bi-Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.